bioRxivCancer BiologyPreprint
ERV-derived dsRNAs induce stress granules that drive neural crest fate to initiate melanoma
Kyle D Drake, Emily FormatoiD, Siras Hakobyan, Rachel A Hongo, Song Yang, Jennifer PoratiD, Owen Sanborn, Anne L Robertson, Dmitry A Kretov, Yi ZhouiD, Daniel CifuentesiD, Manfred Kunz, Hans Binder, Ryan A FlynniD, Leonard I Zon
Abstract
Melanoma arises when melanocytes are oncogenically reprogrammed into neural crest-like cells, but what initiates this switch is unknown. Here we show that endogenous retrovirus (ERV)-derived double stranded RNAs (dsRNAs) induce stress granules (SGs) that drive this fate change. In zebrafish, melanoma progresses through a stage-specific ERV switch: zferv marks precursor cells before crestin activates in tumor cells. Both elements generate dsRNA that triggers eif2ak2-dependent SGs within precursor lesions and through transformation. SGs are tumorigenic as G3BP1 overexpression accelerates melanoma onset, whereas mosaic, melanocyte-specific g3bp1/2 knockout delays it. Small molecule-mediated inhibition of G3BP1/2 eliminates precursor lesions and reduces tumor burden. Similarly, blocking dsRNA sensing prevents SG formation and lowers melanoma incidence. Human nevi and melanomas show analogous, stage-specific ERV programs and SG assembly. In human melanoma cells, SGs sequester and translationally repress SOX10-regulating mRNAs, including the tumor suppressor KMT2D. Mosaic knockout of kmt2d in vivo enhances SOX10-driven neural crest reactivation. Thus, an ERV-SG axis establishes an oncogenic translatome that enables melanoma fate, with diagnostic and therapeutic potential.
- organism: zebrafish
- organism: human
- assay: spatial transcriptomics
- assay: proteomics
- research focus: cancer & tumor microenvironment
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: cell signaling & trafficking
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Loss of prdm1a accelerates melanoma onset and progression
R. Iwanaga, B. Truong, … K. Artinger·bioRxiv·Dec 20, 2019
- Recurrent oncogenic ZC3H18 mutations stabilize endogenous retroviral RNA
Tanzina Tanu, Anna M. Cox, … Megan L. Insco·Cell ReportsPeer-reviewed·Jun 24, 2026
- RIPOR2 promotes multinucleation of melanoma cells downstream of the RAS/ERK oncogenic pathway
Axelle Wilmerding, Aurélie Richard, … Marie-Claire Delfini·iSciencePeer-reviewed·Apr 15, 2026
- BMP-dependent oligoclonal cancer attractor state precedes neural crest fate in melanoma initiation
Alicia M. McConnell, Maggie H. Chassé, … Leonard Ira Zon·bioRxiv·Oct 22, 2024
- SATB2 induction of a neural crest mesenchyme-like program drives invasion and drug resistance in melanoma
M. Fazio, E. van Rooijen, … L. I. Zon·bioRxiv·Nov 1, 2020
- Crosstalk in skin: Loss of desmoglein 1 in keratinocytes inhibits BRAFV600E-induced cellular senescence in human melanocytes
X. Tong, H. E. Burks, … K. J. Green·bioRxiv·Feb 16, 2023